Keyphrases
Receptor-interacting Protein Kinase 1 (RIPK1)
100%
Growth Factors
100%
Insulin-like
100%
Papilloma
100%
A1 Receptor
100%
Kinase Inhibitor
100%
ATP Non-competitive
100%
Antineoplastic Agents
100%
Prostate Cancer
20%
Receptor Antagonist
20%
Insulin Receptor
20%
Phosphorylation
10%
Tumor
10%
Cancer Cells
10%
Anticancer Agents
10%
Tumor Progression
10%
IC50
10%
Breast Cancer
10%
Psoriasis
10%
Metastatic Process
10%
Hematological Malignancies
10%
Mouse Tumor Model
10%
Overactivation
10%
Receptor Tyrosine Kinase
10%
Colorectal Cancer
10%
Cell-free
10%
Autophosphorylation
10%
High Affinity
10%
Cell Growth
10%
Metabolic Pathway
10%
Antiproliferative Activity
10%
Soft Agar
10%
Keratinocytes
10%
Anti-apoptotic Pathways
10%
Antimetastatic
10%
Novel Substrates
10%
Substrate Mimetics
10%
Tertiary Aromatic Amines
10%
Maintenance Process
10%
Metastatic Pathways
10%
Anticancer
10%
Antipsoriatic
10%
Receptor Activity
10%
Non-ATP Competitive
10%
HPV16
10%
Proliferative Disorder
10%
Kinase Assay
10%
Human Keratinocytes (HaCaT)
10%
IGF-1 System
10%
Non-competitive
10%
Cellular Assay
10%
Neoplastic Cells
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
100%
Phosphotransferase Inhibitor
100%
Papilloma
100%
Somatomedin C Receptor
100%
Malignant Neoplasm
20%
Insulin Receptor
20%
Neoplasm
10%
Disease
10%
Tumor Growth
10%
Protein Tyrosine Kinase
10%
IC50
10%
Psoriasis
10%
Breast Cancer
10%
Hematologic Malignancy
10%
Prostate Cancer
10%
Phosphotransferase
10%
Colorectal Carcinoma
10%
Agar
10%
Tumor Model
10%
Antiapoptotic
10%
Anticarcinogen
10%
Antipsoriasis Agent
10%
Aromatic Amine
10%
Human Papillomavirus Type 16
10%